Seroquel in the treatment of aggression and autoaggression
Managing aggressive and self-destructive behaviors is one of the most important issues of psychiatric practice. However, aggression far less frequently becomes the subject of research than depression and anxiety. Clinical psychiatry offers vague definitions of the terms 'aggression' and 'self-destructive behavior' ('auto-aggression'). This investigation aimed at evaluation of efficacy, safety and tolerability of Seroquel in the treatment of mentioned Khuako, V. S.Yutko conditions. According to the CGI scale, 89.5% of patients showed noticeable and significant positive effect by the 21<sup>st</sup> day of medication while by the end of treatment positive effect was found in 94.7%. Only 2 patients (5.3%) showed insignificant improvement in the course of treatment with Seroquel.